DE60121327D1 - Verwendung von lactobacillus casei in immunverstärkenden zusammensetzungen - Google Patents

Verwendung von lactobacillus casei in immunverstärkenden zusammensetzungen

Info

Publication number: DE60121327D1
Authority: DE; Germany
Prior art keywords: immunostable; compositions; lactobacillus casein; lactobacillus; casein
Prior art date: 2000-05-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60121327T

Other languages

English (en)

Other versions

DE60121327T2 (de

Inventor

Eric Postaire

Benjamin Bonavida

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Gervais Danone SA

Original Assignee

Gervais Danone SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-25

Filing date

2001-04-27

Publication date

2006-08-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8850597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121327(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-27 Application filed by Gervais Danone SA filed Critical Gervais Danone SA

2006-08-17 Publication of DE60121327D1 publication Critical patent/DE60121327D1/de

2007-07-26 Application granted granted Critical

2007-07-26 Publication of DE60121327T2 publication Critical patent/DE60121327T2/de

2021-04-28 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

241000186660 Lactobacillus Species 0.000 title 1
239000005018 casein Substances 0.000 title 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title 1
235000021240 caseins Nutrition 0.000 title 1
229940039696 lactobacillus Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Oncology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Biomedical Technology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DE60121327T 2000-05-25 2001-04-27 Verwendung von lactobacillus casei in immunverstärkenden zusammensetzungen Expired - Lifetime DE60121327T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0006679A FR2809312B1 (fr)	2000-05-25	2000-05-25	Utilisation de l. casei dans des compositions immunostimulantes
FR0006679		2000-05-25
PCT/FR2001/001310 WO2001089541A1 (fr)	2000-05-25	2001-04-27	Utilisation de lactobacillus casei dans des peptides immunostimulantes

Publications (2)

Publication Number	Publication Date
DE60121327D1 true DE60121327D1 (de)	2006-08-17
DE60121327T2 DE60121327T2 (de)	2007-07-26

Family

ID=8850597

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60121327T Expired - Lifetime DE60121327T2 (de)	2000-05-25	2001-04-27	Verwendung von lactobacillus casei in immunverstärkenden zusammensetzungen

Country Status (27)

Country	Link
US (1)	US7604809B2 (de)
EP (1)	EP1283714B1 (de)
JP (1)	JP2003534284A (de)
CN (1)	CN1194707C (de)
AR (1)	AR028626A1 (de)
AT (1)	ATE332143T1 (de)
AU (2)	AU2001256435B2 (de)
BG (1)	BG65884B1 (de)
BR (1)	BR0111135A (de)
CA (1)	CA2410350C (de)
CZ (1)	CZ303600B6 (de)
DE (1)	DE60121327T2 (de)
DK (1)	DK1283714T3 (de)
EA (1)	EA005081B1 (de)
ES (1)	ES2267763T3 (de)
FR (1)	FR2809312B1 (de)
HR (1)	HRP20020935A2 (de)
HU (1)	HUP0302041A3 (de)
IL (1)	IL152980A0 (de)
MA (1)	MA25760A1 (de)
MX (1)	MXPA02011636A (de)
NO (1)	NO332369B1 (de)
PL (1)	PL201801B1 (de)
PT (1)	PT1283714E (de)
SK (1)	SK18272002A3 (de)
WO (1)	WO2001089541A1 (de)
ZA (1)	ZA200209087B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6800744B1 (en) *	1997-07-02	2004-10-05	Genome Therapeutics Corporation	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
GB0009294D0 (en)	2000-04-15	2000-05-31	Sec Dep For The Home Departmen	Improvements in and relating to analysis of DNA samples
US9610347B2 (en) *	2001-04-30	2017-04-04	Cortcontrol	Vaccination response for immunodeficiency or high cortisol
CN1317385C (zh) *	2003-05-30	2007-05-23	上海光明乳业股份有限公司	干酪乳杆菌Bd－II菌株及其在降低血脂方面的应用
US20050158294A1 (en)	2003-12-19	2005-07-21	The Procter & Gamble Company	Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en)	2003-12-19	2014-11-04	The Iams Company	Methods of use of probiotic bifidobacteria for companion animals
PL1629850T5 (pl) *	2004-08-24	2013-09-30	Nutricia Nv	Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy
ZA200705844B (en) *	2004-12-15	2008-09-25	Van Der Westhuzen Corne Floris	Detoxifying and immunity-booster composition
EP1683425A1 (de) *	2005-01-21	2006-07-26	Compagnie Gervais Danone	Verwendung von fermentiertem Milchprodukt enthaltend L. Casei zur Herstellung eines Zusammensetzung zur Prävention oder Behandlung Überempfindlichkeitsreaktionen vom verzögerten Typ
ES2264368B1 (es) *	2005-02-11	2007-12-01	Francisco Exposito Mesa	Complemento alimenticio o dietetico compuesto por productos procedentes del lisado de microorganismos.
PL1885383T3 (pl)	2005-05-31	2017-06-30	Iams Europe B.V.	Kocie probiotyczne bifidobakterie
BRPI0611493B1 (pt)	2005-05-31	2022-04-05	Alimentary Health Ltd.	Lactobacilos probióticos felinos
EP2073842B2 (de)	2006-09-10	2023-10-18	Glycotope GmbH	Verwendung von menschlichen zellen von myeloischer leukämie zur expression von antikörpern
FR2912657B1 (fr) *	2007-02-16	2009-04-17	Gervais Danone Sa	Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale.
WO2009021585A1 (en) *	2007-08-13	2009-02-19	Dsm Ip Assets B.V.	Probiotic bacteria for rducing the occurence of symptoms of winter infections
WO2009067000A1 (en) *	2007-11-20	2009-05-28	N.V. Nutricia	Composition with synbiotics
JP2011520435A (ja) *	2008-05-13	2011-07-21	グリコトープゲーエムベーハー	発酵プロセス
EP2119365B1 (de)	2008-05-13	2017-08-16	Glycotope GmbH	Fermentationsprozess
US9771199B2 (en)	2008-07-07	2017-09-26	Mars, Incorporated	Probiotic supplement, process for making, and packaging
EP2153837A1 (de) *	2008-08-14	2010-02-17	Compagnie Gervais Danone	Zusammensetzungen mit Lactobacillus casei zur Verbesserung der Resistenz gegen verbreitete Infektionskrankheiten
FR2937252B1 (fr)	2008-10-17	2011-05-20	Pf Medicament	Association d'un extrait de sureau et d'une souche de l. paracasei.
US10104903B2 (en)	2009-07-31	2018-10-23	Mars, Incorporated	Animal food and its appearance
BR112012016894A2 (pt) *	2010-01-08	2015-09-15	Gervais Danone Sa	lactobacilos com ação antioxidante.
ES2691301T3 (es) *	2010-03-12	2018-11-26	Compagnie Gervais Danone	Bacterias de ácido láctico para la enfermedad celíaca
WO2012049301A1 (en) *	2010-10-15	2012-04-19	Chr. Hansen A/S	Immunoadjuvant
EP2455092A1 (de) *	2010-11-11	2012-05-23	Nestec S.A.	Nicht replizierende probiotische Mikroorganismen als Schutz vor Infektionen der oberen Atemwege
EP2748302B1 (de)	2011-08-22	2018-08-15	Glycotope GmbH	Mikroorganismen mit einem tumor-antigen
WO2014038929A1 (en)	2012-09-07	2014-03-13	N.V. Nutricia	Probiotics for producing antiviral factors
EP3794041B1 (de)	2018-05-18	2023-07-12	Glycotope GmbH	Anti-muc1-antikörper

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05236872A (ja) *	1992-02-27	1993-09-17	Takanashi Nyugyo Kk	乳酸菌含有食品
JP4112021B2 (ja) *	1994-02-16	2008-07-02	明治乳業株式会社	乳酸菌を用いた免疫賦活剤
DK0794707T3 (da) *	1995-01-02	1999-07-26	Gervais Danone Co	Mælkesyreferment og anvendelse deraf til fremstilling af antidiarréiske produkter
EP2241616B1 (de) *	1997-08-21	2012-11-28	New Zealand Dairy Board	Immunitätsverstärkende Milchsäurebakterien
US6699517B2 (en) *	1997-11-28	2004-03-02	Compagnie Gervais Danone	Method for preparing food products by fermenting soy milk with streptococcus thermophilus
IT1298918B1 (it) *	1998-02-20	2000-02-07	Mendes Srl	Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
KR100324441B1 (ko) *	1999-02-08	2002-02-27	이은선	위염, 위궤양, 십이지장궤양 예방을 위한 식품

2000
- 2000-05-25 FR FR0006679A patent/FR2809312B1/fr not_active Expired - Fee Related
2001
- 2001-04-27 MX MXPA02011636A patent/MXPA02011636A/es active IP Right Grant
- 2001-04-27 DK DK01929743T patent/DK1283714T3/da active
- 2001-04-27 AU AU2001256435A patent/AU2001256435B2/en not_active Ceased
- 2001-04-27 AU AU5643501A patent/AU5643501A/xx active Pending
- 2001-04-27 HU HU0302041A patent/HUP0302041A3/hu unknown
- 2001-04-27 ES ES01929743T patent/ES2267763T3/es not_active Expired - Lifetime
- 2001-04-27 CZ CZ20024189A patent/CZ303600B6/cs unknown
- 2001-04-27 JP JP2001585785A patent/JP2003534284A/ja active Pending
- 2001-04-27 SK SK1827-2002A patent/SK18272002A3/sk not_active Application Discontinuation
- 2001-04-27 PL PL358408A patent/PL201801B1/pl unknown
- 2001-04-27 CN CNB018100511A patent/CN1194707C/zh not_active Expired - Fee Related
- 2001-04-27 PT PT01929743T patent/PT1283714E/pt unknown
- 2001-04-27 EA EA200201248A patent/EA005081B1/ru not_active IP Right Cessation
- 2001-04-27 AT AT01929743T patent/ATE332143T1/de active
- 2001-04-27 BR BR0111135-3A patent/BR0111135A/pt not_active IP Right Cessation
- 2001-04-27 IL IL15298001A patent/IL152980A0/xx unknown
- 2001-04-27 EP EP01929743A patent/EP1283714B1/de not_active Expired - Lifetime
- 2001-04-27 US US10/276,315 patent/US7604809B2/en not_active Expired - Fee Related
- 2001-04-27 DE DE60121327T patent/DE60121327T2/de not_active Expired - Lifetime
- 2001-04-27 HR HR20020935A patent/HRP20020935A2/hr not_active Application Discontinuation
- 2001-04-27 CA CA2410350A patent/CA2410350C/fr not_active Expired - Lifetime
- 2001-04-27 WO PCT/FR2001/001310 patent/WO2001089541A1/fr active IP Right Grant
- 2001-05-24 AR ARP010102498A patent/AR028626A1/es unknown
2002
- 2002-11-08 ZA ZA200209087A patent/ZA200209087B/xx unknown
- 2002-11-20 BG BG107299A patent/BG65884B1/bg unknown
- 2002-11-21 NO NO20025595A patent/NO332369B1/no not_active IP Right Cessation
- 2002-12-20 MA MA26968A patent/MA25760A1/fr unknown

Also Published As

Publication number	Publication date
EP1283714A1 (de)	2003-02-19
IL152980A0 (en)	2003-06-24
PL358408A1 (en)	2004-08-09
HRP20020935A2 (en)	2005-02-28
HUP0302041A2 (hu)	2003-09-29
NO20025595D0 (no)	2002-11-21
ES2267763T3 (es)	2007-03-16
AU2001256435B2 (en)	2006-06-29
EA005081B1 (ru)	2004-10-28
BG107299A (bg)	2003-07-31
WO2001089541A1 (fr)	2001-11-29
CA2410350A1 (fr)	2001-11-29
CZ20024189A3 (cs)	2003-05-14
CN1430518A (zh)	2003-07-16
CZ303600B6 (cs)	2013-01-02
CN1194707C (zh)	2005-03-30
MXPA02011636A (es)	2003-05-14
HUP0302041A3 (en)	2005-11-28
AU5643501A (en)	2001-12-03
EP1283714B1 (de)	2006-07-05
US7604809B2 (en)	2009-10-20
BG65884B1 (bg)	2010-04-30
JP2003534284A (ja)	2003-11-18
ZA200209087B (en)	2004-06-30
NO20025595L (no)	2003-01-22
NO332369B1 (no)	2012-09-03
MA25760A1 (fr)	2003-04-01
DK1283714T3 (da)	2006-10-30
AR028626A1 (es)	2003-05-14
PL201801B1 (pl)	2009-05-29
CA2410350C (fr)	2013-04-09
PT1283714E (pt)	2006-11-30
FR2809312A1 (fr)	2001-11-30
US20040029127A1 (en)	2004-02-12
SK18272002A3 (sk)	2003-08-05
EA200201248A1 (ru)	2003-06-26
BR0111135A (pt)	2003-04-08
FR2809312B1 (fr)	2002-07-12
DE60121327T2 (de)	2007-07-26
ATE332143T1 (de)	2006-07-15
HK1055898A1 (en)	2004-01-30

Publication	Publication Date	Title
DE60121327D1 (de)	2006-08-17	Verwendung von lactobacillus casei in immunverstärkenden zusammensetzungen
DE60144013D1 (de)	2011-03-24	Harzzusammensetzung und verwendung derselben
DE60019777D1 (de)	2005-06-02	Zusammensetzung enthaltend caseinprotein und molkenprotein
DE60136181D1 (de)	2008-11-27	3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
ATE297907T1 (de)	2005-07-15	Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase- aktivatoren
CY2014017I2 (el)	2015-12-09	Νεες σουλφαμιδες και η χρηση τους σαν ανταγωνιστικων ληπτων ενδοθηλινης
DE60037322D1 (de)	2008-01-17	Verwendung des Organopolysiloxans M3T in kosmetischen Zusammensetzungen
DE60233029D1 (de)	2009-09-03	"hyperblebbing" bakterielle stämme und ihre verwendung zur herstellung von impfstoffen
DE60140383D1 (de)	2009-12-17	Zementdispergiermittel und dieses enthaltende Zementzusammensetzung
DK0974335T3 (da)	2004-01-26	Kosmetiske vaskesammensætninger og deres anvendelse
EE200200286A (et)	2003-08-15	Uued aminopropüülfosfiinhapped ning nende kasutamine
AU2001256435A1 (en)	2002-02-21	Use of lactobacillus casei in immunostimulatory compositions
EE200300134A (et)	2003-08-15	Uued tiadiasoolid ja oksadiasoolid ning nende kasutamine fosfodiesteraas-7 inhibiitoritena
DE69923554D1 (de)	2005-03-10	Mutantstämme von lactobacillus bulgaricus frei von beta-galactosidase aktivität
DE50107834D1 (de)	2005-12-01	Dispergierung von pigmenten in polyolefinen
DE60119349D1 (de)	2006-06-08	Vollaromatische polyester und polyesterharzzusammensetzung
DE60102122D1 (de)	2004-04-01	Zusammensetzung von Poly-1-Butenharz und dessen Verwendung
DE60237741D1 (de)	2010-11-04	Umstellung von Maschinen- und Last-Charakteristik
DE60118910D1 (de)	2006-05-24	Phosphatkonversionsüberzugverfahren und zusammensetzung
EP1673353A4 (de)	2007-03-28	Übergangszustandstruktur und inhibitoren von thymidinphosphorylase
DE60109730D1 (de)	2005-05-04	Zementzusatzmittel und Zementzusammensetzung
NO20031522D0 (no)	2003-04-03	Ny stamme av lactobacillus paracasei
PL360839A1 (pl)	2004-09-20	Zastosowanie szczepów owczych parapoksywirusów przeciw zwłóknieniu narządów
HUP0303936A3 (en)	2004-12-28	Novel composition and use
DE59905561D1 (de)	2003-06-18	Verwendung von eisenglimmer bei der herstellung von gussformen

Legal Events

Date	Code	Title	Description
2007-06-28	8363	Opposition against the patent
2007-11-29	8327	Change in the person/name/address of the patent owner	Owner name: COMPAGNIE GERVAIS DANONE, PARIS, FR